These data provide the first molecular insight into CD8+ T-cell-induced β-cell destruction via recognition of the insulin B chain in this important disease model of T1D and demonstrate a novel flexible peptide-MHC binding mode that has broad implications for T-cell antigen presentation. This evidence concerns the gene HLA-C and type 1 diabetes mellitus.